Vanta Bioscience Limited (BOM:540729)
India · Delayed Price · Currency is INR 22.07
0.00 (0.00%)
At close: Jun 3, 2026
Vanta Bioscience Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1.08 | -47.75 | -23.16 | -64.81 | 0.88 |
Depreciation & Amortization | 12.3 | 44.16 | 44.97 | 26.7 | 13.16 |
Loss (Gain) From Sale of Assets | - | - | -0.42 | - | - |
Other Operating Activities | 6.83 | -37.87 | -7.62 | 21.04 | 24.87 |
Change in Accounts Receivable | -8.14 | 6.38 | -11.82 | -8.25 | 8.81 |
Change in Inventory | -10.45 | 10.13 | -3.63 | 0.78 | 25.29 |
Change in Other Net Operating Assets | -53.82 | 0.86 | 28.52 | 18.26 | -20.22 |
Operating Cash Flow | -52.19 | -24.09 | 26.84 | -6.28 | 52.79 |
Operating Cash Flow Growth | - | - | - | - | -24.29% |
Capital Expenditures | -68.72 | -66.94 | -34.05 | -286.89 | -171.81 |
Sale of Property, Plant & Equipment | - | - | 0.92 | - | - |
Other Investing Activities | - | - | -0 | 227.8 | - |
Investing Cash Flow | -68.72 | -66.94 | -33.13 | -59.09 | -171.81 |
Short-Term Debt Issued | - | 38.98 | 11.05 | 5.13 | - |
Long-Term Debt Issued | 118.16 | 137.12 | 77.19 | 117.81 | 92.28 |
Total Debt Issued | 118.16 | 176.1 | 88.24 | 122.95 | 92.28 |
Short-Term Debt Repaid | -42.09 | - | - | - | -3.32 |
Long-Term Debt Repaid | - | -84.79 | -50.32 | - | - |
Total Debt Repaid | -42.09 | -84.79 | -50.32 | - | -3.32 |
Net Debt Issued (Repaid) | 76.07 | 91.3 | 37.92 | 122.95 | 88.97 |
Issuance of Common Stock | 40 | 41 | 26.5 | - | 29.82 |
Other Financing Activities | 4.73 | -40.67 | -57.49 | -58.86 | -23.47 |
Financing Cash Flow | 120.8 | 91.63 | 6.93 | 64.09 | 95.32 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | -0.56 |
Net Cash Flow | -0.12 | 0.61 | 0.64 | -1.28 | -24.26 |
Free Cash Flow | -120.92 | -91.02 | -7.21 | -293.17 | -119.02 |
Free Cash Flow Margin | -611.96% | -463.56% | -7.41% | -467.13% | -118.81% |
Free Cash Flow Per Share | -16.75 | -14.42 | -1.14 | -46.45 | -18.86 |
Cash Interest Paid | - | 40.19 | 57.23 | 56.05 | 23.47 |
Levered Free Cash Flow | -101.5 | -84.64 | -32.47 | -323.16 | -130.68 |
Unlevered Free Cash Flow | -96.64 | -59.52 | 3.3 | -288.13 | -116.01 |
Change in Working Capital | -72.41 | 17.37 | 13.07 | 10.79 | 13.87 |